These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
174 related items for PubMed ID: 9461090
1. Thrombospondin 1 precedes and predicts the development of tubulointerstitial fibrosis in glomerular disease in the rat. Hugo C, Shankland SJ, Pichler RH, Couser WG, Johnson RJ. Kidney Int; 1998 Feb; 53(2):302-11. PubMed ID: 9461090 [Abstract] [Full Text] [Related]
3. [Localized expressing tendency of nuclear transcription factor kappa-B, pro-fibrosis genetic factors and fibronectin mRNA in renal tissues in proteinuria overload nephrotic young rats]. Ma H, Li XH, Li Z, Yin HQ, Wang XH, Li WW, Li H, Liu Q. Zhonghua Er Ke Za Zhi; 2005 Nov; 43(11):814-8. PubMed ID: 16316526 [Abstract] [Full Text] [Related]
5. Thrombospondin-1 is a major activator of TGF-beta in fibrotic renal disease in the rat in vivo. Daniel C, Wiede J, Krutzsch HC, Ribeiro SM, Roberts DD, Murphy-Ullrich JE, Hugo C. Kidney Int; 2004 Feb; 65(2):459-68. PubMed ID: 14717916 [Abstract] [Full Text] [Related]
10. Thrombospondin peptides are potent inhibitors of mesangial and glomerular endothelial cell proliferation in vitro and in vivo. Hugo CP, Pichler RP, Schulze-Lohoff E, Pröls F, Adler S, Krutsch HC, Murphy-Ullrich JE, Couser WG, Roberts DD, Johnson RJ. Kidney Int; 1999 Jun; 55(6):2236-49. PubMed ID: 10354272 [Abstract] [Full Text] [Related]
11. Late angiotensin II receptor blockade in progressive rat mesangioproliferative glomerulonephritis: new insights into mechanisms. Villa L, Boor P, Konieczny A, Kunter U, van Roeyen CR, Denecke B, Gan L, Neusser MA, Cohen CD, ERCB Consortium;, Eitner F, Scholl T, Ostendorf T, Floege J. J Pathol; 2013 Apr; 229(5):672-84. PubMed ID: 23192593 [Abstract] [Full Text] [Related]
12. Expression of transforming growth factor-beta-inducible gene-h3 in normal and cyclosporine-treated rat kidney. Sun BK, Li C, Lim SW, Jung JY, Lee SH, Kim IS, Kim YS, Kim J, Bang BK, Yang CW. J Lab Clin Med; 2004 Mar; 143(3):175-83. PubMed ID: 15007308 [Abstract] [Full Text] [Related]
13. Transformation of interstitial fibroblasts and tubulointerstitial fibrosis in diabetic nephropathy. Ina K, Kitamura H, Tatsukawa S, Takayama T, Fujikura Y, Shimada T. Med Electron Microsc; 2002 Jun; 35(2):87-95. PubMed ID: 12181650 [Abstract] [Full Text] [Related]
14. L-Arginine treatment may prevent tubulointerstitial nephropathy caused by germanium dioxide. Yanagisawa H, Yamazaki N, Sato G, Wada O. Kidney Int; 2000 Jun; 57(6):2275-84. PubMed ID: 10844598 [Abstract] [Full Text] [Related]
15. Connective tissue growth factor expressed in tubular epithelium plays a pivotal role in renal fibrogenesis. Okada H, Kikuta T, Kobayashi T, Inoue T, Kanno Y, Takigawa M, Sugaya T, Kopp JB, Suzuki H. J Am Soc Nephrol; 2005 Jan; 16(1):133-43. PubMed ID: 15574513 [Abstract] [Full Text] [Related]
16. Transforming growth factor-beta receptors in self-limited vs. chronic progressive nephritis in rats. Watanabe T, Yamamoto T, Ikegaya N, Fujigaki Y, Suzuki H, Togawa A, Fukasawa H, Nagase M, Hishida A. J Pathol; 2002 Nov; 198(3):397-406. PubMed ID: 12375273 [Abstract] [Full Text] [Related]
17. Tubulointerstitial disease in glomerulonephritis. Potential role of osteopontin (uropontin). Pichler R, Giachelli CM, Lombardi D, Pippin J, Gordon K, Alpers CE, Schwartz SM, Johnson RJ. Am J Pathol; 1994 May; 144(5):915-26. PubMed ID: 8178943 [Abstract] [Full Text] [Related]